SEC filing · 8-K

INSMED Inc: Executive or director change

Insmed Chief Financial Officer Sara Bonstein will step down effective October 30, 2026, while the company reaffirmed its full-year 2026 financial guidance.

Filed October 5, 2026

Neutral news

What happened

Sara Bonstein will step down as Chief Financial Officer on October 30, 2026, after nearly seven years with the company.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to INSMED Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.